沙门氏菌病

Pegues DA, Miller SI. Salmonella species, including Salmonella Typhi. In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010:2887-2903.

Talbot EA, Gagnon ER, Greenblatt J. Common ground for the control of multi-drug resistant Salmonella in ground beef. Clin Infect Dis. 2006;42:1455-1462.

• 全文
• 摘要

King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.

• 全文
• 摘要

World Health Organization. Foodborne disease outbreaks: guidelines for investigation and control. 2008. http://whqlibdoc.who.int/ (last accessed 4 April 2017).

• 全文

1.  Salmon DE, Smith T. The bacterium of swine-plague. Am Month Micr J. 1886;7:214.

2.  Kauffman F. The diagnosis of Salmonella types. Springfield, IL: Charles C Thomas; 1950.

3.  Centers for Disease Control and Prevention. National enteric disease surveillance: Salmonella annual report, 2013. June 2016. https://www.cdc.gov/ (last accessed 4 April 2017).

• 全文

4.  Spina A, Kerr KG, Cormican M, et al. Spectrum of enteropathogens detected by the FilmArray GI panel in a multicentre study of community-acquired gastroenteritis. Clin Microbiol Infect. 2015;21:719-728.

• 全文
• 摘要

5.  Voetsch AC, Van Gilder TJ, Angulo FJ, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004;38:S127-S134.

• 全文
• 摘要

6.  Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5:607-625.

• 全文
• 摘要

7.  Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States - major pathogens. Emerg Infect Dis. 2011;17:7-15.

• 摘要

8.  Crim SM, Griffin PM, Tauxe R, et al; Centers for Disease Control and Prevention (CDC). Preliminary incidence and trends of infection with pathogens transmitted commonly through food: Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2006-2014. MMWR Morb Mortal Wkly Rep. 2015;64:495-499.

• 全文
• 摘要

9.  Centers for Disease Control and Prevention. An atlas of Salmonella in the United States, 1968-2011. 2013. http://www.cdc.gov (last accessed 4 April 2017).

• 全文

10.  Public Health England. Salmonella by serotype 2000 to 2010. December 2010. https://www.gov.uk (last accessed 4 April 2017).

• 全文

11.  Greig JD, Lee MB. Enteric outbreaks in long-term care facilities and recommendations for prevention: a review. Epidemiol Infect. 2009;137:145-155.

• 摘要

12.  Barton Behravesh C, Mody RK, Jungk J, et al. 2008 outbreak of Salmonella Saintpaul infections associated with raw produce. N Engl J Med. 2011;364:918-927.

• 全文
• 摘要

13.  Painter JA, Hoekstra RM, Ayers T, et al. Attribution of foodborne illnesses, hospitalizations, and deaths to food commodities by using outbreak data, United States, 1998-2008. Emerg Infect Dis. 2013;19:407-415.

• 全文
• 摘要

14.  Adkins HJ, Escamilla J, Santiago LT, et al. Two-year survey of etiologic agents of diarrheal disease at San Lazaro Hospital, Manila, Republic of the Philippines. J Clin Microbiol. 1987;25:1143-1147.

• 全文
• 摘要

15.  Saidi SM, Iijima Y, Sang WK, et al. Epidemiological study on infectious diarrheal diseases in children in a coastal rural area of Kenya. Microbiol Immunol. 1997;41:773-778.

• 摘要

16.  Morpeth SC, Ramadhani HO, Crump JA. Invasive non-Typhi Salmonella disease in Africa. Clin Infect Dis. 2009;49:606-611.

• 全文
• 摘要

17.  Majowicz SE, Musto J, Scallan E, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010;50:882-889.

• 全文
• 摘要

18.  Gordon MA. Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis. Curr Opin Infect Dis. 2011;24:484-489.

• 摘要

19.  Okoro CK, Kingsley RA, Connor TR, et al. Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nat Genet. 2012;44:1215-1221.

• 全文
• 摘要

20.  Gascon J. Epidemiology, etiology, and pathophysiology of traveler's diarrhea. Digestion. 2006;73(suppl 1):102-108.

• 摘要

21.  Braden CR. Salmonella enterica serotype Enteritidis and eggs: a national epidemic in the United States. Clin Infect Dis. 2006;43:512-517.

• 全文
• 摘要

22.  Fierer J, Swancutt M. Non-typhoid Salmonella: a review. Curr Clin Top Infect Dis. 2000;20:134-157.

• 摘要

23.  Blaser MJ, Newman LS. A review of human salmonellosis: I. infective dose. Rev Infect Dis. 1982;4:1096-1106.

• 摘要

24.  Mintz ED, Cartter ML, Hadler JL, et al. Dose-response effects in an outbreak of Salmonella enteritidis. Epidemiol Infect. 1994;112:13-23.

• 摘要

25.  Giannella RA, Broitman SA, Zamcheck N. Salmonella enteritis. I. Role of reduced gastric secretion in pathogenesis. Am J Dig Dis. 1971;16:1000-1006.

• 摘要

26.  Cook GC. Infective gastroenteritis and its relationship to reduced gastric acidity. Scand J Gastroenterol Suppl. 1985;111:17-23.

• 摘要

27.  Shimoni Z, Pitlik S, Leibovici L, et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis. 1999;28:822-827.

• 摘要

28.  Huang CF, Chen PL, Liu MF, et al. Nontyphoidal Salmonella bacteremia in patients with connective tissue diseases. J Microbiol Immunol Infect. 2012;45:350-355.

• 摘要

29.  Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32:263-269.

• 全文
• 摘要

30.  Pegues DA, Miller SI. Salmonella species, including Salmonella Typhi. In: Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010:2887-2903.

31.  Celum CL, Chaisson RE, Rutherford GW, et al. Incidence of salmonellosis in patients with AIDS. J Infect Dis. 1987;156:998-1002.

• 摘要

32.  Peña-Sagredo JL, Fariñas MC, Perez-Zafrilla B, et al. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy. Clin Exp Rheumatol. 2009;27:920-925.

• 摘要

33.  Croswell A, Amir E, Teggatz P, et al. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun. 2009;77:2741-2753.

• 全文
• 摘要

34.  Molbak K. Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. Clin Infect Dis. 2005;41:1613-1620.

• 全文
• 摘要

35.  Ryan CA, Nickels MK, Hargrett-Bean NT, et al. Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA. 1987;258:3269-3274.

• 摘要

36.  Mouy R, Fischer A, Vilmer E, et al. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989;114:555-560.

• 摘要

37.  Kaye D, Gill FA, Hook EW. Factors influencing host resistance to Salmonella infections: the effects of hemolysis and erythrophagocytosis. Am J Med Sci. 1967;254:205-215.

• 摘要

38.  Talbot EA, Gagnon ER, Greenblatt J. Common ground for the control of multi-drug resistant Salmonella in ground beef. Clin Infect Dis. 2006;42:1455-1462.

• 全文
• 摘要

39.  Woodward DL, Khakhria R, Johnson WM. Human salmonellosis associated with exotic pets. J Clin Microbiol. 1997;35:2786-2790.

• 全文
• 摘要

40.  National Association of State Public Health Veterinarians, Inc; Centers for Disease Control and Prevention (CDC). Compendium of measures to prevent disease associated with animals in public settings, 2011: National Association of State Public Health Veterinarians, Inc. MMWR Recomm Rep. 2011;60(RR-04):1-24.

• 全文
• 摘要

41.  Finley R, Reid-Smith R, Weese S. Human health implications of Salmonella-contaminated natural pet treats and raw pet food. Clin Infect Dis. 2006;42:686-691.

• 全文
• 摘要

42.  Centers for Disease Control and Prevention (CDC). Human salmonellosis associated with animal-derived pet treats - United States and Canada, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:702-705.

• 全文
• 摘要

43.  Saphra I, Winter JW. Clinical manifestations of salmonellosis in man: an evaluation of 7779 infections identified at the New York Salmonella Center. N Engl J Med. 1957;256:1128-1134.

• 摘要

44.  Buss SN, Leber A, Chapin K, et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol. 2015;53:915-925.

• 全文
• 摘要

45.  Mandomando I, Macete E, Sigaúque B, et al. Invasive non-typhoidal Salmonella in Mozambican children. Trop Med Int Health. 2009;14:1467-1474.

• 全文
• 摘要

46.  Preziosi MJ, Kandel SM, Guiney DG, et al. Microbiological analysis of nontyphoidal Salmonella strains causing distinct syndromes of bacteremia or enteritis in HIV/AIDS patients in San Diego, California. J Clin Microbiol. 2012;50:3598-3603.

• 全文
• 摘要

47.  Feasey NA, Dougan G, Kingsley RA, et al. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379:2489-2499.

• 全文
• 摘要

48.  Guerrant RL, Van Gilder T, Steiner TS, et al; Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32:331-351.

• 全文
• 摘要

49.  Szajewska H, Dziechciarz P. Gastrointestinal infections in the pediatric population. Curr Opin Gastroenterol. 2010;26:36-44.

• 摘要

50.  Carter B, Fedorowicz Z. Antiemetic treatment for acute gastroenteritis in children: an updated Cochrane systematic review with meta-analysis and mixed treatment comparison in a Bayesian framework. BMJ Open. 2012;2:e000622.

• 全文
• 摘要

51.  Cayley WE Jr. Antiemetics for acute gastroenteritis-related vomiting in children and adolescents. Am Fam Physician. 2012;85:1054-1056.

• 摘要

52.  Cheng A. Emergency department use of oral ondansetron for acute gastroenteritis-related vomiting in infants and children. Paediatr Child Health. 2011;16:177-179

• 全文
• 摘要

53.  Fedorowicz Z, Jagannath VA, Carter B. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev. 2011;(9):CD005506.

• 全文
• 摘要

54.  Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev. 2012;(11):CD001167.

• 全文
• 摘要

55.  Carlstedt G, Dahl P, Niklasson PM, et al. Norfloxacin treatment of salmonellosis does not shorten the carrier stage. Scand J Infect Dis. 1990;22:553-556.

• 摘要

56.  Bassily S, Hyams KC, el-Masry NA, et al. Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt. Am J Trop Med Hyg. 1994;51:219-223.

• 摘要

57.  Guarino A, Ashkenazi S, Gendrel D, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014;59:132-152.

• 全文
• 摘要

58.  Gendrel D, Cohen R; European Society for Pediatric Infectious Diseases, European Society for Gastroenterology, Hepatology and Nutrition. Bacterial diarrheas and antibiotics: European recommendations. Arch Pediatr. 2008;15(suppl 2):S93-S96. [in French]

• 摘要

59.  Gordon MA, Banda HT, Gondwe M, et al. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS. 2002;16:1633-1641.

• 摘要

60.  Hung CC, Hsieh SM, Hsiao CF, et al. Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy. AIDS. 2001;15:645-647.

• 摘要

61.  Gilbert DN, Chambers HF, Eliopoulos GM, et al. The Sanford guide to antimicrobial therapy, 47th ed. Sperryville, VA: Antimicrobial Therapy, Inc.; 2017.

62.  Crump JA, Medalla FM, Joyce KW, et al. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother. 2011;55:1148-1154.

• 全文
• 摘要

63.  Nakaya H, Yasuhara A, Yoshimura K, et al. Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC. Emerg Infect Dis. 2003;9:255-257.

• 摘要

64.  Whichard JM, Gay K, Stevenson JE, et al. Human Salmonella and concurrent decreased susceptibility to quinolones and extended-spectrum cephalosporins. Emerg Infect Dis. 2007;13:1681-1688.

• 摘要

65.  Al-Mashhadani M, Hewson R, Vivancos R, et al. Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections. Emerg Infect Dis. 2011;17:123-125.

• 全文
• 摘要

66.  Sjölund-Karlsson M, Rickert R, Matar C, et al. Salmonella isolates with decreased susceptibility to extended-spectrum cephalosporins in the United States. Foodborne Pathog Dis. 2010;7:1503-1509.

• 摘要

67.  Wadula J, von Gottberg A, Kilner D, et al. Nosocomial outbreak of extended-spectrum beta-lactamase-producing Salmonella isangi in pediatric wards. Pediatr Infect Dis J. 2006;25:843-844.

• 摘要

68.  Usha G, Chunderika M, Prashini M, et al. Characterization of extended-spectrum beta-lactamases in Salmonella spp. at a tertiary hospital in Durban, South Africa. Diagn Microbiol Infect Dis. 2008;62:86-91.

• 摘要

69.  Lunguya O, Lejon V, Phoba MF, et al. Antimicrobial resistance in invasive non-typhoid Salmonella from the Democratic Republic of the Congo: emergence of decreased fluoroquinolone susceptibility and extended-spectrum beta lactamases. PLoS Negl Trop Dis. 2013;7:e2103.

• 全文
• 摘要

70.  Tang HJ, Ko WC, Chen CC, et al. In vitro and in vivo intracellular killing effects of tigecycline against clinical nontyphoid Salmonella isolates using ceftriaxone as a comparator. Antimicrob Agents Chemother. 2011;55:2755-2759.

• 全文
• 摘要

71.  Tang HJ, Chen CC, Zhang CC, et al. Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies. Antimicrob Agents Chemother. 2012;56:2916-2922.

• 全文
• 摘要

72.  White NJ, Dung NM, Vinh H, et al. Fluoroquinolone antibiotics in children with multidrug resistant typhoid. Lancet. 1996;348:547.

• 摘要

73.  Angulo FJ, Johnson KR, Tauxe RV, et al. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist. 2000;6:77-83.

• 摘要

74.  Arlet G, Barrett TJ, Butaye P, et al. Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology. Microbes Infect. 2006;8:1945-1954.

• 摘要

75.  King CK, Glass R, Bresee JS, et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52:1-16.

• 全文
• 摘要

76.  UNICEF Supply Division. New formulation of oral rehydration salts (ORS) with reduced osmolarity. Technical Bulletin no 9. April 2004. http://www.unicef.org/supply (last accessed 4 April 2017).

• 全文

77.  DeCamp LR, Byerley JS, Doshi N, et al. Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis. Arch Pediatr Adolesc Med. 2008;162:858-865.

• 全文
• 摘要

78.  European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013. http:// www.ema.europa.eu/ (last accessed 4 April 2017).

• 全文

79.  Adefurin A, Sammons H, Jacqz-Aigrain, et al. Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child. 2011;96:874-880.

• 全文
• 摘要

80.  Freerksen E, Rosenfield M, Freerksen R, et al. Treatment of chronic Salmonella carriers. Chemotherapy. 1977;23:192.

• 摘要

81.  Ferreccio C, Morris JG Jr, Valdivieso C, et al. Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers. J Infect Dis. 1988;157:1235-1239.

• 摘要

82.  DuPont HL. Quinolones in Salmonella typhi infection. Drugs. 1993;45:119-124.

• 摘要

83.  Diridl G, Pichler H, Wolf D. Treatment of chronic salmonella carriers with ciprofloxacin. Eur J Clin Microbiol. 1986;5:260-261.

• 摘要

84.  Clementi KJ. Trimethoprim-sulfamethoxazole in the treatment of carriers of Salmonella. J Infect Dis. 1973;128:738-742.

• 摘要

85.  Rodriguez-Noriega E, Andrade-Villanueva J, Amaya-Tapia G. Quinolones in the treatment of Salmonella carriers. Rev Infect Dis. 1989;11:S1179-S1187.

• 摘要

86.  Dinbar A, Altmann G, Tulcinsky DB. The treatment of chronic biliary salmonella carriers. Am J Med. 1969;47:236-242.

• 摘要

87.  Cummings PL, Sorvillo F, Kuo T. Salmonellosis-related mortality in the United States, 1990-2006. Foodborne Pathog Dis. 2010;7:1393-1399.

• 摘要

88.  Chimalizeni Y, Kawaza K, Molyneux E. The epidemiology and management of non typhoidal salmonella infections. Adv Exp Med Biol. 2010;659:33-46.

• 摘要

89.  Kaneko K, Nonomura Y, Watanabe K, et al. Infected abdominal aortic aneurysm caused by nontyphoid Salmonella in an immunocompromised patient with rheumatoid arthritis. J Infect Chemother. 2009;15:312-315.

• 摘要

90.  Chen PL, Lee CC, Li CY, et al. A simple scoring algorithm predicting vascular infections in adults with nontyphoid Salmonella bacteremia. Clin Infect Dis. 2012;55:194-200.

• 摘要

91.  Lee AT, Hall RG, Pile KD. Reactive joint symptoms following an outbreak of Salmonella typhimurium phage type 135a. J Rheumatol. 2005;32:524-527.

• 摘要

92.  Buchwald DS, Blaser MJ. A review of human salmonellosis: II. duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis. 1984:6:345-356.

• 摘要

93.  Lee MB, Greig JD. A review of nosocomial Salmonella outbreaks: infection control interventions found effective. Public Health. 2013;127:199-206.

• 摘要

94.  World Health Organization. Foodborne disease outbreaks: guidelines for investigation and control. 2008. http://whqlibdoc.who.int/ (last accessed 4 April 2017).

• 全文